Syracuse Science and Technology Law Reporter
By Elliot Fruchtman
This book describes the current state of the pharmaceutical industry and discusses how current government regulations affect scientific innovation. Moreover, the author describes the advantages and disadvantages of various attempts to change the current system. In addition, the author analyzes the Vioxx litigation to illustrate his theory that government regulations restrain innovation and development of new drugs.
[view abstract] | [download PDF]
By Ryan Crawford
Advances in genetic modification techniques enable the creation of crops with commercially desirable characteristics. Recombined gene sequences may be inserted into a crop’s genome to protect it against herbicides, insects, or rodents. In the United States, a variety of patent and trade secret protections are afforded the developers of such crops and other genetically modified organisms. The scope of these protections has been interpreted more broadly over the years by the courts. This broadening of legal protections has occurred as the relationship between the developers of seed, the government, and farmers has changed from one in which seed development was largely the work of the government and academia, especially public universities and land grant colleges, to one in which seed development is increasingly privatized, or accomplished through the alliance of private and public forces.
[view abstract] | [download PDF]
By Ann M. Alexander
Today, one out of every four Americans searches the World Wide Web for health related information and prescription drug research. However, the number of Americans that purchase their pharmaceuticals over the internet still remains low.
This note discusses the various types of internet pharmacies, the reasons patients utilize these entities, and current regulation of the industry. Allocating responsibility to both the State and Federal governments, the note suggests a solution to the problems posed by current regulation of internet pharmacies.
[view abstract] | [download PDF]
By Sheila Schwallie
Some governments have already developed opinions and drafted regulations on “designer babies” as bio-technological advances are getting close to making it a reality for parents to design their babies before in vitro fertilization. In the United Kingdom, heavy regulation of sex selection has been requested while the United States has not yet voiced a unified opinion on the issue despite the increasing use of sex selection procedures.
[view abstract] | [download PDF]